1887

Abstract

We tested the efficacy of the esterase encoded by from in recombinant subunit and DNA caseous lymphadenitis (CLA) vaccines. This target was predicted as one of the best CLA vaccine candidates by mature epitope density analysis.

Gene was cloned into two different vectors (pAE for subunit vaccine and pTARGET for DNA vaccine). Four groups of 15 mice each were immunized with the recombinant esterase rCP09720 associated with aluminium hydroxide adjuvant (G1), pTARGET/cp DNA vaccine (G2), a naked pTARGET (G3) or PBS as a negative control (G4). Immunization occurred in two doses intercalated by a 21 day interval. Twenty-one days after the last dose administration, animals were challenged with a virulent MIC-6 strain.

G1 showed high levels of IgG1 and IgG2a on days 21 and 42 post-immunization and a significant level of IFN-γ (<0.05), suggesting a Th1 response. The protection levels obtained were 58.3 and 16.6 % for G1 and G2, respectively.

The subunit vaccine composed of the recombinant esterase rCP09720 and Al(OH) is a promising antigenic formulation for use against CLA.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000477
2017-05-01
2019-12-13
Loading full text...

Full text loading...

/deliver/fulltext/jmm/66/5/635.html?itemId=/content/journal/jmm/10.1099/jmm.0.000477&mimeType=html&fmt=ahah

References

  1. Baird GJ, Fontaine MC. Corynebacterium pseudotuberculosis and its role in ovine caseous lymphadenitis. J Comp Pathol 2007;137:179–210 [CrossRef][PubMed]
    [Google Scholar]
  2. Dorella FA, Fachin MS, Billault A, Dias Neto E, Soravito C et al. Construction and partial characterization of a Corynebacterium pseudotuberculosis bacterial artificial chromosome library through genomic survey sequencing. Genet Mol Res 2006;5:653–663[PubMed]
    [Google Scholar]
  3. Bastos BL, Portela RWD, Dorella FA, Ribeiro D, Seyffert N et al. Corynebacterium pseudotuberculosis: immunological responses in animal models and zoonotic potential. J Clin Cell Immunol 2012;S4–S5
    [Google Scholar]
  4. Guimarães AS, Carmo FB, Heinemann MB, Portela RW, Meyer R et al. High sero-prevalence of caseous lymphadenitis identified in slaughterhouse samples as a consequence of deficiencies in sheep farm management in the state of Minas Gerais, Brazil. BMC Vet Res 2011;7:68 [CrossRef][PubMed]
    [Google Scholar]
  5. Ruiz JC, D'Afonseca V, Silva A, Ali A, Pinto AC et al. Evidence for reductive genome evolution and lateral acquisition of virulence functions in two Corynebacterium pseudotuberculosis strains. PLoS One6:e18551 [CrossRef]
    [Google Scholar]
  6. Radusky LG, Hassan S, Lanzarotti E, Tiwari S, Jamal S et al. An integrated structural proteomics approach along the druggable genome of Corynebacterium pseudotuberculosis species for putative druggable targets. BMC Genomics 2015;16:S9 [CrossRef][PubMed]
    [Google Scholar]
  7. Dorella FA, Pacheco LG, Seyffert N, Portela RW, Meyer R et al. Antigens of Corynebacterium pseudotuberculosis and prospects for vaccine development. Expert Rev Vaccines 2009;8:205–213 [CrossRef][PubMed]
    [Google Scholar]
  8. Simmons CP, Dunstan SJ, Tachedjian M, Krywult J, Hodgson AL et al. Vaccine potential of attenuated mutants of Corynebacterium pseudotuberculosis in sheep. Infect Immun 1998;66:474–479[PubMed]
    [Google Scholar]
  9. Meyer R, Carminati R, Cerqueira RB, Vale V, Viegas S et al. Evaluation of humoral immune response in goats inoculated with a live attenuated lyophilized vaccine against Corynebacterium pseudotubercusis. Rev Ciênc Méd Biol 2002;1:42–48
    [Google Scholar]
  10. Lima DD, Rebouças MF, Portela RW, Vale V, Pacheco A et al. Comparison of two chromogens in the development of an immunoenzymatic assay (ELISA) for detection of immunoglobulins specific against Corynebacterium pseudotuberculosis. Vet Immunol Immunopathol 2009;128:333 [CrossRef]
    [Google Scholar]
  11. Hodgson AL, Carter K, Tachedjian M, Krywult J, Corner LA et al. Efficacy of an ovine caseous lymphadenitis vaccine formulated using a genetically inactive form of the Corynebacterium pseudotuberculosis phospholipase D. Vaccine 1999;17:802–808 [CrossRef][PubMed]
    [Google Scholar]
  12. Menzies PI, Hwang YT, Prescott JF. Comparison of an interferon-γ to a phospholipase D enzyme-linked immunosorbent assay for diagnosis of Corynebacterium pseudotuberculosis infection in experimentally infected goats. Vet Microbiol 2004;100:129–137 [CrossRef][PubMed]
    [Google Scholar]
  13. Hassan SS, Guimarães LC, Pereira UP, Islam A, Ali A et al. Complete genome sequence of Corynebacterium pseudotuberculosis biovar Ovis strain P54B96 isolated from antelope in South Africa obtained by rapid next generation sequencing technology. Stand Genomic Sci 2012;7:189–199 [CrossRef][PubMed]
    [Google Scholar]
  14. Silva A, Schneider MP, Cerdeira L, Barbosa MS, Ramos RT et al. Complete genome sequence of Corynebacterium pseudotuberculosis I19, a strain isolated from a cow in Israel with bovine mastitis. J Bacteriol 2011;193:323–324 [CrossRef][PubMed]
    [Google Scholar]
  15. Trost E, Ott L, Schneider J, Schröder J, Jaenicke S et al. The complete genome sequence of Corynebacterium pseudotuberculosis FRC41 isolated from a 12-year-old girl with necrotizing lymphadenitis reveals insights into gene-regulatory networks contributing to virulence. BMC Genomics 2010;11:728 [CrossRef][PubMed]
    [Google Scholar]
  16. D'Afonseca V, Prosdocimi F, Dorella FA, Pacheco LG, Moraes PM et al. Survey of genome organization and gene content of Corynebacterium pseudotuberculosis. Microbiol Res 2010;165:312–320 [CrossRef][PubMed]
    [Google Scholar]
  17. D'Afonseca V, Moraes PM, Dorella FA, Pacheco LG, Meyer R et al. A description of genes of Corynebacterium pseudotuberculosis useful in diagnostics and vaccine applications. Genet Mol Res 2008;7:252–260 [CrossRef][PubMed]
    [Google Scholar]
  18. Costa MP, Mcculloch JA, Almeida SS, Dorella FA, Fonseca CT et al. Molecular characterization of the Corynebacterium pseudotuberculosis hsp60-hsp10 operon, and evaluation of the immune response and protective efficacy induced by hsp60 DNA vaccination in mice. BMC Res Notes 2011;4:243 [CrossRef][PubMed]
    [Google Scholar]
  19. Selim SA, Ghoneim ME, Mohamed KHF. Vaccinal efficacy of genetically inactivated phospholipase D against caseous lymphadenitis in small ruminants. Int J Microbiol Res 2010;1:129–136
    [Google Scholar]
  20. Silva JW, Droppa-Almeida D, Borsuk S, Azevedo V, Portela RW et al. Corynebacterium pseudotuberculosis cp09 mutant and cp40 recombinant protein partially protect mice against caseous lymphadenitis. BMC Vet Res 2014;10:965 [CrossRef][PubMed]
    [Google Scholar]
  21. Santos AR, Pereira VB, Barbosa E, Baumbach J, Pauling J et al. Mature epitope density – a strategy for target selection based on immunoinformatics and exported prokaryotic proteins. BMC Genomics 2013;14:S4 [CrossRef][PubMed]
    [Google Scholar]
  22. Rezende AF, Brum AA, Reis CG, Angelo HR, Leal KS et al. In silico identification of Corynebacterium pseudotuberculosis antigenic targets and application in immunodiagnosis. J Med Microbiol 2016;65:521–529 [CrossRef][PubMed]
    [Google Scholar]
  23. Mariano DC, Sousa TJ, Pereira FL, Aburjaile F, Barh D et al. Whole-genome optical mapping reveals a mis-assembly between two rRNA operons of Corynebacterium pseudotuberculosis strain 1002. BMC Genomics 2016;17:315 [CrossRef][PubMed]
    [Google Scholar]
  24. Moura-Costa LF, Bahia RC, Carminati R, Vale VL, Paule BJ et al. Evaluation of the humoral and cellular immune response to different antigens of Corynebacterium pseudotuberculosis in Canindé goats and their potential protection against caseous lymphadenitis. Vet Immunol Immunopathol 2008;126:131–141 [CrossRef][PubMed]
    [Google Scholar]
  25. Green MR, Sambrook J. Molecular Cloning – A Laboratoy Manual, 4th ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2012
    [Google Scholar]
  26. Ramos CR, Abreu PA, Nascimento AL, Ho PL. A high-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal His-tagged fusion peptide. Braz J Med Biol Res 2004;37:1103–1109 [CrossRef][PubMed]
    [Google Scholar]
  27. Forster KM, Hartwig DD, Seixas FK, Bacelo KL, Amaral M et al. A conserved region of leptospiral immunoglobulin-like A and B proteins as a DNA vaccine elicits a prophylactic immune response against leptospirosis. Clin Vaccine Immunol 2013;20:725–731 [CrossRef][PubMed]
    [Google Scholar]
  28. Fontaine MC, Baird G, Connor KM, Rudge K, Sales J et al. Vaccination confers significant protection of sheep against infection with a virulent United Kingdom strain of Corynebacterium pseudotuberculosis. Vaccine 2006;24:5986–5996 [CrossRef][PubMed]
    [Google Scholar]
  29. Rebouças MF, Loureiro D, Bastos BL, Moura-Costa LF, Hanna SA et al. Development of an indirect ELISA to detect Corynebacterium pseudotuberculosis specific antibodies in sheep employing T1 strain culture supernatant as antigen. Pesquisa Vet Bras 2013;33:1296–1302 [CrossRef]
    [Google Scholar]
  30. Vale VL, Silva MC, de Souza AP, Trindade SC, de Moura-Costa LF et al. Humoral and cellular immune responses in mice against secreted and somatic antigens from a Corynebacterium pseudotuberculosis attenuated strain: immune response against a C. pseudotuberculosis strain. BMC Vet Res 2016;12:195 [CrossRef][PubMed]
    [Google Scholar]
  31. Jacob E, Hod-Dvorai R, Ben-Mordechai OL, Boyko Y, Avni O et al. Dual function of polycomb group proteins in differentiated murine T helper (CD4+) cells. J Mol Signal 2011;6:5 [CrossRef][PubMed]
    [Google Scholar]
  32. Cardona PJ, Gordillo S, Díaz J, Tapia G, Amat I et al. Widespread bronchogenic dissemination makes DBA/2 mice more susceptible than C57BL/6 mice to experimental aerosol infection with Mycobacterium tuberculosis. Infect Immun 2003;71:5845–5854 [CrossRef][PubMed]
    [Google Scholar]
  33. Matsui H, Yokoyama T, Tanaka C, Sunaga H, Koitabashi N et al. Pressure mediated hypertrophy and mechanical stretch up-regulate expression of the long form of leptin receptor (ob-Rb) in rat cardiac myocytes. BMC Cell Biol 2012;13:37 [CrossRef][PubMed]
    [Google Scholar]
  34. Heydenreich B, Bellinghausen I, Lund L, Henmar H, Lund G et al. Adjuvant effects of aluminium hydroxide-adsorbed allergens and allergoids - differences in vivo and in vitro. Clin Exp Immunol 2014;176:310–319 [CrossRef][PubMed]
    [Google Scholar]
  35. Andreasen LV, Hansen LB, Andersen P, Agger EM, Dietrich J et al. Aluminium hydroxide potentiates a protective Th1 biased immune response against polio virus that allows for dose sparing in mice and rats. Vaccine 2015;33:1873–1879 [CrossRef][PubMed]
    [Google Scholar]
  36. Abbas A, Lichtman A, Shiv P. Cellular and Molecular Immunology, 8th ed. Philadelphia, PA: Elsevier; 2014
    [Google Scholar]
  37. Holstad G, Teige J, Larsen HJ. Corynebacterium pseudotuberculosis infection in goats. VIII. the effect of vaccination against experimental infection. Acta Vet Scand 1989;30:275–283[PubMed]
    [Google Scholar]
  38. Alharbi KBA. Control of abscess disease of sheep by concurrent vaccination, zinc injection and antiseptic washing. Res Vet Sci 2011;4:9–13 [CrossRef]
    [Google Scholar]
  39. Braga WU. Protection in alpacas against Corynebacterium pseudotuberculosis using different bacterial components. Vet Microbiol 2007;119:297–303 [CrossRef][PubMed]
    [Google Scholar]
  40. Pinho JMR, Dorella FA, Coelho KS, Fonseca CT, Cardoso FC et al. Immunization with recombinant Corynebacterium pseudotuberculosis heat-shock protein (Hsp)-60 is able to induce an immune response in mice, but fails to confer protection against infection. Open Vet Sci J 2009;3:22–27 [CrossRef]
    [Google Scholar]
  41. Droppa-Almeida D, Vivas WL, Silva KK, Rezende AF, Simionatto S et al. Recombinant CP40 from Corynebacterium pseudotuberculosis confers protection in mice after challenge with a virulent strain. Vaccine 2016;34:1091–1096 [CrossRef][PubMed]
    [Google Scholar]
  42. Abdulhaqq SA, Weiner DB. DNA vaccines: developing new strategies to enhance immune responses. Immunol Res 2008;42:219–232 [CrossRef][PubMed]
    [Google Scholar]
  43. Schrijver RS, Langedijk JP, Keil GM, Middel WG, Maris-Veldhuis M et al. Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV. Vaccine 1997;15:1908–1916 [CrossRef][PubMed]
    [Google Scholar]
  44. Chaplin PJ, de Rose R, Boyle JS, Mcwaters P, Kelly J et al. Targeting improves the efficacy of a DNA vaccine against Corynebacterium pseudotuberculosis in sheep. Infect Immun 1999;67:6434–6438[PubMed]
    [Google Scholar]
  45. de Rose R, Tennent J, Mcwaters P, Chaplin PJ, Wood PR et al. Efficacy of DNA vaccination by different routes of immunisation in sheep. Vet Immunol Immunopathol 2002;90:55–63 [CrossRef][PubMed]
    [Google Scholar]
  46. Brogden KA, Chedid L, Cutlip RC, Lehmkuhl HD, Sacks J et al. Effect of muramyl dipeptide on immunogenicity of Corynebacterium pseudotuberculosis whole-cell vaccines in mice and lambs. Am J Vet Res 1990;51:200–202[PubMed]
    [Google Scholar]
  47. Cameron CM, Minnaar JL, Engelbrecht MM, Purdom MR. Immune response of merino sheep to inactivated Corynebacterium pseudotuberculosis vaccine. Onderstepoort J Vet Res 1972;39:24[PubMed]
    [Google Scholar]
  48. Brown CC, Olander HJ, Biberstein EL, Morse SM. Use of a toxoid vaccine to protect goats against intradermal challenge exposure to Corynebacterium pseudotuberculosis. Am J Vet Res 1986;47:1116–1119[PubMed]
    [Google Scholar]
  49. El-Enbaawy MI, Saad MM, Selim SA. Humoral and cellular immune responses of a murine model against Corynebacterium pseudotuberculosis antigens. Egypt J Immunol 2005;12:13–19[PubMed]
    [Google Scholar]
  50. Holstad G. Corynebacterium pseudotuberculosis infection in goats. IX. The effect of vaccination against natural infection. Acta Vet Scand 1989;30:285–293[PubMed]
    [Google Scholar]
  51. Gorman JK, Gabriel M, Maclachlan NJ, Nieto N, Foley J et al. Pilot immunization of mice infected with an equine strain of Corynebacterium pseudotuberculosis. Vet Ther 2010;11:E1E8[PubMed]
    [Google Scholar]
  52. Rebouças MF, Portela RW, Lima DD, Loureiro D, Bastos BL et al. Corynebacterium pseudotuberculosis secreted antigen-induced specific gamma-interferon production by peripheral blood leukocytes: potential diagnostic marker for caseous lymphadenitis in sheep and goats. J Vet Diagn Invest 2011;23:213–220 [CrossRef][PubMed]
    [Google Scholar]
  53. Lan DT, Taniguchi S, Makino S, Shirahata T, Nakane A et al. Role of endogenous tumor necrosis factor alpha and gamma interferon in resistance to Corynebacterium pseudotuberculosis infection in mice. Microbiol Immunol 1998;42:863–870 [CrossRef][PubMed]
    [Google Scholar]
  54. de Souza AP, Vale VL, Silva MC, Araújo IB, Trindade SC et al. MAPK involvement in cytokine production in response to Corynebacterium pseudotuberculosis infection. BMC Microbiol 2014;14:230 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000477
Loading
/content/journal/jmm/10.1099/jmm.0.000477
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error